5 Pharmaceutical preparations for diagnostic assessment and therapeutic targeting of RNA, namely, for ribosomal RNA, miRNA, siRNA, exoRNA, RNA fragments, and viral RNA for medical and scientific research purposes; pharmaceutical preparations for the treatment and prevention of a wide variety of diseases and disorders, namely, genetic diseases and disorders, proliferative diseases and disorders, neoplasias, tumourous diseases and disorders, and cancer; pharmaceutical preparations, namely, RNA-targeting therapeutics for the treatment and prevention a wide variety of diseases and disorders namely, genetic diseases and disorders, proliferative diseases and disorders, neoplasias, tumourous diseases and disorders, and cancer; pharmaceutical products for the prevention and treatment of a wide variety of diseases and disorders, namely, genetic diseases and disorders, proliferative diseases and disorders, neoplasias, tumourous diseases and disorders, and cancer; biologic preparations and compounds for the treatment and prevention of genetic diseases and disorders, proliferative diseases and disorders, neoplasias, tumourous diseases and disorders, and cancer